

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 7.00676435 |
| 2 | regulation of histone H3-K27 methylation (GO:0061085) | 6.11023642 |
| 3 | DNA deamination (GO:0045006) | 4.71433308 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.53616593 |
| 5 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.42311120 |
| 6 | regulation of RNA export from nucleus (GO:0046831) | 4.40813373 |
| 7 | nuclear pore complex assembly (GO:0051292) | 4.39373882 |
| 8 | mannose metabolic process (GO:0006013) | 4.32185102 |
| 9 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.30121988 |
| 10 | histone H4 deacetylation (GO:0070933) | 4.26660214 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 4.26369985 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 4.26369985 |
| 13 | proline biosynthetic process (GO:0006561) | 4.24239922 |
| 14 | regulation of translational fidelity (GO:0006450) | 4.20008951 |
| 15 | DNA strand elongation (GO:0022616) | 4.15381895 |
| 16 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.09706240 |
| 17 | telomere maintenance via recombination (GO:0000722) | 4.03289212 |
| 18 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.95044643 |
| 19 | DNA topological change (GO:0006265) | 3.91434227 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.89790639 |
| 21 | regulation of histone H3-K4 methylation (GO:0051569) | 3.77179692 |
| 22 | negative regulation of histone methylation (GO:0031061) | 3.71471598 |
| 23 | creatine metabolic process (GO:0006600) | 3.70184290 |
| 24 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.69298489 |
| 25 | mitotic recombination (GO:0006312) | 3.68393589 |
| 26 | nucleobase biosynthetic process (GO:0046112) | 3.63971963 |
| 27 | DNA replication initiation (GO:0006270) | 3.63834996 |
| 28 | glucose 6-phosphate metabolic process (GO:0051156) | 3.60469765 |
| 29 | telomere maintenance via telomere lengthening (GO:0010833) | 3.58351147 |
| 30 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.56832957 |
| 31 | Peyers patch development (GO:0048541) | 3.56832957 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 3.53227724 |
| 33 | nucleosome disassembly (GO:0006337) | 3.52178803 |
| 34 | protein-DNA complex disassembly (GO:0032986) | 3.52178803 |
| 35 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.51136191 |
| 36 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.48426753 |
| 37 | mitotic chromosome condensation (GO:0007076) | 3.47493326 |
| 38 | histone H3 deacetylation (GO:0070932) | 3.46412227 |
| 39 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.43196894 |
| 40 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.41478112 |
| 41 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.41203191 |
| 42 | nuclear pore organization (GO:0006999) | 3.39997577 |
| 43 | DNA unwinding involved in DNA replication (GO:0006268) | 3.39641198 |
| 44 | modulation by virus of host process (GO:0019054) | 3.37561169 |
| 45 | oxaloacetate metabolic process (GO:0006107) | 3.37333152 |
| 46 | regulation of early endosome to late endosome transport (GO:2000641) | 3.35854938 |
| 47 | histone H2A acetylation (GO:0043968) | 3.35273711 |
| 48 | stress granule assembly (GO:0034063) | 3.34008385 |
| 49 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.33982645 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32587882 |
| 51 | mitotic sister chromatid segregation (GO:0000070) | 3.31186685 |
| 52 | regulation of histone methylation (GO:0031060) | 3.29485817 |
| 53 | erythrocyte maturation (GO:0043249) | 3.23669202 |
| 54 | regulation of chromatin binding (GO:0035561) | 3.22556462 |
| 55 | telomere organization (GO:0032200) | 3.21719746 |
| 56 | negative regulation of cell size (GO:0045792) | 3.21001485 |
| 57 | snRNA metabolic process (GO:0016073) | 3.19882670 |
| 58 | pore complex assembly (GO:0046931) | 3.19734769 |
| 59 | telomere maintenance (GO:0000723) | 3.19388276 |
| 60 | sister chromatid segregation (GO:0000819) | 3.18669425 |
| 61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.16336449 |
| 62 | regulation of ARF GTPase activity (GO:0032312) | 3.14599869 |
| 63 | cullin deneddylation (GO:0010388) | 3.09710367 |
| 64 | protein export from nucleus (GO:0006611) | 3.09267112 |
| 65 | mitotic nuclear envelope disassembly (GO:0007077) | 3.09077943 |
| 66 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.08616857 |
| 67 | protein deneddylation (GO:0000338) | 3.08311044 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.07356430 |
| 69 | histone H3-K4 methylation (GO:0051568) | 3.06184535 |
| 70 | formation of translation preinitiation complex (GO:0001731) | 3.06099801 |
| 71 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.06027682 |
| 72 | negative T cell selection (GO:0043383) | 3.05910102 |
| 73 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.05669426 |
| 74 | mitochondrion transport along microtubule (GO:0047497) | 3.05669426 |
| 75 | histone H3-K9 demethylation (GO:0033169) | 3.04006458 |
| 76 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.03189659 |
| 77 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.02620785 |
| 78 | DNA replication checkpoint (GO:0000076) | 3.02248539 |
| 79 | viral mRNA export from host cell nucleus (GO:0046784) | 3.01636743 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.01495860 |
| 81 | erythrocyte development (GO:0048821) | 3.01486544 |
| 82 | negative thymic T cell selection (GO:0045060) | 3.01295390 |
| 83 | proline metabolic process (GO:0006560) | 3.00910151 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.00786289 |
| 85 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.99269874 |
| 86 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.99269874 |
| 87 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.99135955 |
| 88 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.99135955 |
| 89 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.99135955 |
| 90 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.98824565 |
| 91 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.98529677 |
| 92 | negative regulation of ligase activity (GO:0051352) | 2.98529677 |
| 93 | response to epidermal growth factor (GO:0070849) | 2.96087525 |
| 94 | proteasome assembly (GO:0043248) | 2.96031197 |
| 95 | membrane disassembly (GO:0030397) | 2.95125913 |
| 96 | nuclear envelope disassembly (GO:0051081) | 2.95125913 |
| 97 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.94851202 |
| 98 | translesion synthesis (GO:0019985) | 2.91078047 |
| 99 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.88232417 |
| 100 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.87784623 |
| 101 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.87784623 |
| 102 | sequestering of actin monomers (GO:0042989) | 2.87501575 |
| 103 | postreplication repair (GO:0006301) | 2.87414919 |
| 104 | granulocyte differentiation (GO:0030851) | 2.87342216 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86838491 |
| 106 | response to vitamin A (GO:0033189) | 2.86346567 |
| 107 | RNA stabilization (GO:0043489) | 2.85799163 |
| 108 | mRNA stabilization (GO:0048255) | 2.85799163 |
| 109 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.83068612 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.83068612 |
| 111 | natural killer cell differentiation (GO:0001779) | 2.82582116 |
| 112 | positive regulation of histone deacetylation (GO:0031065) | 2.81918050 |
| 113 | tricarboxylic acid metabolic process (GO:0072350) | 2.81597320 |
| 114 | 2-oxoglutarate metabolic process (GO:0006103) | 2.81434511 |
| 115 | gas transport (GO:0015669) | 2.80043645 |
| 116 | establishment of mitochondrion localization (GO:0051654) | 2.79754841 |
| 117 | positive regulation of B cell differentiation (GO:0045579) | 2.78003146 |
| 118 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.77345022 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77165781 |
| 120 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.76750518 |
| 121 | CENP-A containing nucleosome assembly (GO:0034080) | 2.76360667 |
| 122 | histone H3-K4 trimethylation (GO:0080182) | 2.75384696 |
| 123 | maturation of SSU-rRNA (GO:0030490) | 2.74598455 |
| 124 | retinoic acid receptor signaling pathway (GO:0048384) | 2.73932372 |
| 125 | modulation by symbiont of host cellular process (GO:0044068) | 2.73743263 |
| 126 | histone deacetylation (GO:0016575) | 2.71331144 |
| 127 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71265672 |
| 128 | thymic T cell selection (GO:0045061) | 2.71210728 |
| 129 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.71013015 |
| 130 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.69842831 |
| 131 | tRNA methylation (GO:0030488) | 2.69540601 |
| 132 | mismatch repair (GO:0006298) | 2.69338586 |
| 133 | maternal placenta development (GO:0001893) | 2.67996704 |
| 134 | pentose-phosphate shunt (GO:0006098) | 2.67993703 |
| 135 | GMP metabolic process (GO:0046037) | 2.67745086 |
| 136 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.67406188 |
| 137 | dosage compensation (GO:0007549) | 2.67217498 |
| 138 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.66848503 |
| 139 | termination of RNA polymerase III transcription (GO:0006386) | 2.66848503 |
| 140 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.66640933 |
| 141 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.66640933 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66604939 |
| 143 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.66216777 |
| 144 | oxygen transport (GO:0015671) | 2.65575407 |
| 145 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.65274824 |
| 146 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.65274824 |
| 147 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.64205838 |
| 148 | regulation of mitotic spindle organization (GO:0060236) | 2.62814237 |
| 149 | chromatin remodeling at centromere (GO:0031055) | 2.62490292 |
| 150 | spliceosomal snRNP assembly (GO:0000387) | 2.62334705 |
| 151 | negative regulation of mRNA metabolic process (GO:1903312) | 2.62250043 |
| 152 | histone methylation (GO:0016571) | 2.61746098 |
| 153 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.60572560 |
| 154 | negative regulation of mRNA processing (GO:0050686) | 2.60169596 |
| 155 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.59971017 |
| 156 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.59934952 |
| 157 | cell cycle G1/S phase transition (GO:0044843) | 2.59934952 |
| 158 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.59413319 |
| 159 | base-excision repair (GO:0006284) | 2.59154973 |
| 160 | regulation of erythrocyte differentiation (GO:0045646) | 2.59019755 |
| 161 | DNA replication-independent nucleosome organization (GO:0034724) | 2.58792948 |
| 162 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.58792948 |
| 163 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.58457478 |
| 164 | negative regulation of phagocytosis (GO:0050765) | 2.58349372 |
| 165 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.58101210 |
| 166 | 7-methylguanosine mRNA capping (GO:0006370) | 2.57512258 |
| 167 | nuclear envelope organization (GO:0006998) | 2.57283815 |
| 168 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.57164160 |
| 169 | DNA-dependent DNA replication (GO:0006261) | 2.56859340 |
| 170 | maturation of 5.8S rRNA (GO:0000460) | 2.56314283 |
| 171 | vesicle coating (GO:0006901) | 2.55681146 |
| 172 | histone lysine demethylation (GO:0070076) | 2.55200858 |
| 173 | regulation of ARF protein signal transduction (GO:0032012) | 2.55183580 |
| 174 | DNA damage induced protein phosphorylation (GO:0006975) | 2.54934979 |
| 175 | spliceosomal complex assembly (GO:0000245) | 2.54547236 |
| 176 | positive regulation of nuclease activity (GO:0032075) | 2.54251156 |
| 177 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.54132519 |
| 178 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.52977961 |
| 179 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.52352733 |
| 180 | RNA capping (GO:0036260) | 2.51527832 |
| 181 | 7-methylguanosine RNA capping (GO:0009452) | 2.51527832 |
| 182 | positive regulation of cell cycle arrest (GO:0071158) | 2.51366596 |
| 183 | pseudouridine synthesis (GO:0001522) | 2.49138531 |
| 184 | snRNA processing (GO:0016180) | 2.48318341 |
| 185 | IMP biosynthetic process (GO:0006188) | 2.47774645 |
| 186 | replication fork processing (GO:0031297) | 2.45963459 |
| 187 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44952610 |
| 188 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.44592686 |
| 189 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.44592686 |
| 190 | isotype switching (GO:0045190) | 2.44592686 |
| 191 | positive regulation of ligase activity (GO:0051351) | 2.43815475 |
| 192 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.43676183 |
| 193 | mRNA splicing, via spliceosome (GO:0000398) | 2.43234954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.27625996 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.57922444 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.42069477 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.15550659 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.13152867 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.08765533 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.97681521 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.96205288 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.92538081 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.90378439 |
| 11 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.85962993 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.67151364 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.62776197 |
| 14 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.60024534 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58431328 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49401418 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.48128958 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47397999 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.45269786 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42822036 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.37679265 |
| 22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.36729545 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35128238 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.34961032 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.29376197 |
| 26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.29011591 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25898891 |
| 28 | * NCOR1_26117541_ChIP-Seq_K562_Human | 2.24054247 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.23255323 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17162831 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.16577326 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.14768918 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.14441165 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.12732080 |
| 35 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.10133116 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07083970 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04559636 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.03181187 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.02101589 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.01774658 |
| 41 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.01751553 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01413848 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.95297195 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95121107 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93285108 |
| 46 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93254813 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90375932 |
| 48 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.90236458 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.88860414 |
| 50 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.88707692 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.87738062 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.86562155 |
| 53 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82143663 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80328688 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79490843 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79427786 |
| 57 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78032649 |
| 58 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.77194046 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.76365300 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75802754 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74330675 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73585255 |
| 63 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.73170860 |
| 64 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73107638 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72537601 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.70503952 |
| 67 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69589421 |
| 68 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.68655739 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.67481965 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.64739682 |
| 71 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.64721316 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.62695168 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62515475 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61819601 |
| 75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60387182 |
| 76 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59701354 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57265885 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56013715 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55185623 |
| 80 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52175394 |
| 81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52164384 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.51569703 |
| 83 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.50375500 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49878281 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49287108 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49053545 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48255392 |
| 88 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.48048911 |
| 89 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.46134166 |
| 90 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.45304031 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.44670787 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42954300 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.41835484 |
| 94 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41814602 |
| 95 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.40794718 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38288872 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36823605 |
| 98 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.35743686 |
| 99 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35690696 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34760090 |
| 101 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34416431 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.34307697 |
| 103 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34023939 |
| 104 | MYB_26560356_Chip-Seq_TH2_Human | 1.33743637 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.32148515 |
| 106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30029824 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29832978 |
| 108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.29368615 |
| 109 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27652518 |
| 110 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26891838 |
| 111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26363622 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25576652 |
| 113 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25437120 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25373656 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24949622 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23526946 |
| 117 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23333670 |
| 118 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22976285 |
| 119 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22861363 |
| 120 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20338869 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 1.19456789 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.18935236 |
| 123 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17244228 |
| 124 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16264925 |
| 125 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15798081 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14162383 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14121801 |
| 128 | MAF_26560356_Chip-Seq_TH1_Human | 1.13280132 |
| 129 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.12670259 |
| 130 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12286903 |
| 131 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12096587 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09879644 |
| 133 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07896566 |
| 134 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07795030 |
| 135 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07722346 |
| 136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06027301 |
| 137 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05911937 |
| 138 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04632231 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04475400 |
| 140 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02666630 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02080052 |
| 142 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01985638 |
| 143 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.01438485 |
| 144 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01233396 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01206628 |
| 146 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00982173 |
| 147 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00941557 |
| 148 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00792645 |
| 149 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00790990 |
| 150 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00551905 |
| 151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00441908 |
| 152 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00034954 |
| 153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99130927 |
| 154 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99098251 |
| 155 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98886664 |
| 156 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98243408 |
| 157 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97822086 |
| 158 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96689871 |
| 159 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96005776 |
| 160 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93398961 |
| 161 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93301988 |
| 162 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93200679 |
| 163 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91728200 |
| 164 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90588288 |
| 165 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85703110 |
| 166 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85317578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.96166042 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.81898838 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.67122077 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.65571254 |
| 5 | MP0000678_abnormal_parathyroid_gland | 3.39553364 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.28144703 |
| 7 | MP0005671_abnormal_response_to | 3.25779602 |
| 8 | MP0008058_abnormal_DNA_repair | 3.22421117 |
| 9 | MP0003763_abnormal_thymus_physiology | 3.14072961 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.13982994 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.99321987 |
| 12 | MP0003077_abnormal_cell_cycle | 2.85290068 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.69604914 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.68766237 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.67306419 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.54733925 |
| 17 | MP0000685_abnormal_immune_system | 2.46481336 |
| 18 | MP0009785_altered_susceptibility_to | 2.44797278 |
| 19 | MP0002398_abnormal_bone_marrow | 2.42978428 |
| 20 | MP0008057_abnormal_DNA_replication | 2.36808675 |
| 21 | MP0001800_abnormal_humoral_immune | 2.26744044 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.24748568 |
| 23 | MP0004233_abnormal_muscle_weight | 2.12900567 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.12739976 |
| 25 | MP0001819_abnormal_immune_cell | 2.10096808 |
| 26 | MP0008260_abnormal_autophagy | 2.06055083 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 2.05928341 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.02237697 |
| 29 | MP0000716_abnormal_immune_system | 1.99479633 |
| 30 | MP0002249_abnormal_larynx_morphology | 1.98542174 |
| 31 | MP0000490_abnormal_crypts_of | 1.97363643 |
| 32 | MP0002723_abnormal_immune_serum | 1.96588107 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.95145288 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.94259534 |
| 35 | MP0002722_abnormal_immune_system | 1.90282768 |
| 36 | MP0002429_abnormal_blood_cell | 1.88824186 |
| 37 | MP0008995_early_reproductive_senescence | 1.87118522 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.85479345 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.85479345 |
| 40 | MP0005025_abnormal_response_to | 1.82038590 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.80679435 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.77830461 |
| 43 | MP0009840_abnormal_foam_cell | 1.75433270 |
| 44 | MP0005387_immune_system_phenotype | 1.74554423 |
| 45 | MP0001790_abnormal_immune_system | 1.74554423 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.70619574 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.70172918 |
| 48 | MP0003866_abnormal_defecation | 1.66739501 |
| 49 | MP0003786_premature_aging | 1.66559927 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.64537206 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.62204926 |
| 52 | MP0005083_abnormal_biliary_tract | 1.61499563 |
| 53 | MP0000015_abnormal_ear_pigmentation | 1.59625133 |
| 54 | MP0004858_abnormal_nervous_system | 1.55728284 |
| 55 | MP0002132_abnormal_respiratory_system | 1.50962913 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.49941243 |
| 57 | MP0002405_respiratory_system_inflammati | 1.49694718 |
| 58 | MP0004147_increased_porphyrin_level | 1.46775799 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.44332637 |
| 60 | MP0002019_abnormal_tumor_incidence | 1.42484090 |
| 61 | MP0002419_abnormal_innate_immunity | 1.40802910 |
| 62 | MP0003787_abnormal_imprinting | 1.40617088 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.38080420 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.37806559 |
| 65 | MP0005409_darkened_coat_color | 1.37216517 |
| 66 | MP0003121_genomic_imprinting | 1.36332155 |
| 67 | MP0003123_paternal_imprinting | 1.35901901 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.33924300 |
| 69 | MP0000313_abnormal_cell_death | 1.31992886 |
| 70 | MP0002095_abnormal_skin_pigmentation | 1.31153637 |
| 71 | MP0008932_abnormal_embryonic_tissue | 1.28884202 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.27399832 |
| 73 | MP0003436_decreased_susceptibility_to | 1.25261416 |
| 74 | MP0004947_skin_inflammation | 1.24187998 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.20839798 |
| 76 | MP0003724_increased_susceptibility_to | 1.19835610 |
| 77 | MP0001849_ear_inflammation | 1.18039943 |
| 78 | MP0001853_heart_inflammation | 1.16421108 |
| 79 | MP0001873_stomach_inflammation | 1.14376825 |
| 80 | MP0000609_abnormal_liver_physiology | 1.13792026 |
| 81 | MP0000350_abnormal_cell_proliferation | 1.11773625 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.11576192 |
| 83 | MP0003172_abnormal_lysosome_physiology | 1.11208200 |
| 84 | MP0003984_embryonic_growth_retardation | 1.10566915 |
| 85 | MP0001672_abnormal_embryogenesis/_devel | 1.08744034 |
| 86 | MP0005380_embryogenesis_phenotype | 1.08744034 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 1.08506153 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.08192645 |
| 89 | MP0002006_tumorigenesis | 1.07979258 |
| 90 | MP0005375_adipose_tissue_phenotype | 1.07043965 |
| 91 | MP0002970_abnormal_white_adipose | 1.05106398 |
| 92 | MP0001730_embryonic_growth_arrest | 1.04931555 |
| 93 | MP0000003_abnormal_adipose_tissue | 1.04559650 |
| 94 | MP0009672_abnormal_birth_weight | 1.03863406 |
| 95 | MP0002088_abnormal_embryonic_growth/wei | 1.02770298 |
| 96 | MP0002086_abnormal_extraembryonic_tissu | 1.02282450 |
| 97 | MP0009931_abnormal_skin_appearance | 1.01281935 |
| 98 | MP0003303_peritoneal_inflammation | 1.00530105 |
| 99 | MP0000858_altered_metastatic_potential | 0.98550933 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.97675167 |
| 101 | MP0010630_abnormal_cardiac_muscle | 0.97436386 |
| 102 | MP0009115_abnormal_fat_cell | 0.94193733 |
| 103 | MP0004859_abnormal_synaptic_plasticity | 0.94176499 |
| 104 | MP0002933_joint_inflammation | 0.93305082 |
| 105 | MP0005360_urolithiasis | 0.93210444 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.93099654 |
| 107 | MP0001188_hyperpigmentation | 0.92471051 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 0.91112709 |
| 109 | MP0006054_spinal_hemorrhage | 0.90785084 |
| 110 | MP0001915_intracranial_hemorrhage | 0.90446839 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.90058752 |
| 112 | MP0005621_abnormal_cell_physiology | 0.87489309 |
| 113 | MP0003948_abnormal_gas_homeostasis | 0.86349625 |
| 114 | MP0006292_abnormal_olfactory_placode | 0.86291935 |
| 115 | MP0006082_CNS_inflammation | 0.85328638 |
| 116 | MP0002080_prenatal_lethality | 0.85154270 |
| 117 | MP0000598_abnormal_liver_morphology | 0.84350860 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.82825128 |
| 119 | MP0001764_abnormal_homeostasis | 0.82476612 |
| 120 | MP0008469_abnormal_protein_level | 0.82000287 |
| 121 | MP0009697_abnormal_copulation | 0.81689301 |
| 122 | MP0010307_abnormal_tumor_latency | 0.79690889 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79687924 |
| 124 | MP0005310_abnormal_salivary_gland | 0.79445579 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.78793344 |
| 126 | MP0000747_muscle_weakness | 0.78287520 |
| 127 | MP0002210_abnormal_sex_determination | 0.77887605 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.77073488 |
| 129 | MP0002877_abnormal_melanocyte_morpholog | 0.76736412 |
| 130 | MP0001119_abnormal_female_reproductive | 0.75786123 |
| 131 | MP0003385_abnormal_body_wall | 0.74635005 |
| 132 | MP0003718_maternal_effect | 0.74304430 |
| 133 | MP0001727_abnormal_embryo_implantation | 0.72484059 |
| 134 | MP0009278_abnormal_bone_marrow | 0.72402904 |
| 135 | MP0000759_abnormal_skeletal_muscle | 0.72147956 |
| 136 | MP0004381_abnormal_hair_follicle | 0.71555686 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.71258599 |
| 138 | MP0003191_abnormal_cellular_cholesterol | 0.70083582 |
| 139 | MP0000372_irregular_coat_pigmentation | 0.68282729 |
| 140 | MP0002075_abnormal_coat/hair_pigmentati | 0.68039604 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.67863905 |
| 142 | MP0000358_abnormal_cell_content/ | 0.67714350 |
| 143 | MP0003315_abnormal_perineum_morphology | 0.66877802 |
| 144 | MP0000477_abnormal_intestine_morphology | 0.66218302 |
| 145 | MP0002160_abnormal_reproductive_system | 0.65556101 |
| 146 | MP0005384_cellular_phenotype | 0.65192400 |
| 147 | MP0001186_pigmentation_phenotype | 0.64368253 |
| 148 | MP0002102_abnormal_ear_morphology | 0.62550331 |
| 149 | MP0000371_diluted_coat_color | 0.61803327 |
| 150 | MP0001697_abnormal_embryo_size | 0.60499084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cholecystitis (HP:0001082) | 5.94050535 |
| 2 | Abnormal gallbladder physiology (HP:0012438) | 5.94050535 |
| 3 | Truncus arteriosus (HP:0001660) | 5.36238134 |
| 4 | Reticulocytosis (HP:0001923) | 5.05599866 |
| 5 | Hyperthyroidism (HP:0000836) | 4.90326072 |
| 6 | IgM deficiency (HP:0002850) | 4.38047092 |
| 7 | Seborrheic dermatitis (HP:0001051) | 4.13770605 |
| 8 | Bowel incontinence (HP:0002607) | 4.10345885 |
| 9 | Hypertensive crisis (HP:0100735) | 3.94719912 |
| 10 | Thrombocytosis (HP:0001894) | 3.92967576 |
| 11 | Atelectasis (HP:0100750) | 3.90266454 |
| 12 | Type I transferrin isoform profile (HP:0003642) | 3.82541297 |
| 13 | Abnormal large intestine physiology (HP:0012700) | 3.79821186 |
| 14 | Polycythemia (HP:0001901) | 3.72980503 |
| 15 | Reduced antithrombin III activity (HP:0001976) | 3.72861980 |
| 16 | Aplastic anemia (HP:0001915) | 3.72407200 |
| 17 | Abnormality of reticulocytes (HP:0004312) | 3.61465194 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58851267 |
| 19 | Ankyloglossia (HP:0010296) | 3.57133750 |
| 20 | IgG deficiency (HP:0004315) | 3.37655337 |
| 21 | Peripheral hypomyelination (HP:0007182) | 3.30634270 |
| 22 | Cholelithiasis (HP:0001081) | 3.18082243 |
| 23 | Disproportionate tall stature (HP:0001519) | 3.15563481 |
| 24 | Birth length less than 3rd percentile (HP:0003561) | 3.10983244 |
| 25 | Hypoparathyroidism (HP:0000829) | 3.10347572 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.02698193 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00044399 |
| 28 | Obstructive lung disease (HP:0006536) | 3.00044399 |
| 29 | Chromsome breakage (HP:0040012) | 2.97269142 |
| 30 | Type 2 muscle fiber atrophy (HP:0003554) | 2.96132502 |
| 31 | Recurrent bronchitis (HP:0002837) | 2.94908236 |
| 32 | Reticulocytopenia (HP:0001896) | 2.94502117 |
| 33 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.92131106 |
| 34 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.92131106 |
| 35 | Abnormal protein glycosylation (HP:0012346) | 2.92131106 |
| 36 | Abnormal glycosylation (HP:0012345) | 2.92131106 |
| 37 | T lymphocytopenia (HP:0005403) | 2.91612383 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.91489465 |
| 39 | Abnormality of DNA repair (HP:0003254) | 2.90775234 |
| 40 | Myositis (HP:0100614) | 2.88542771 |
| 41 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.88160813 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.87638034 |
| 43 | Abnormality of the tricuspid valve (HP:0001702) | 2.87049960 |
| 44 | Abnormality of T cells (HP:0002843) | 2.86012108 |
| 45 | Hyperacusis (HP:0010780) | 2.80759279 |
| 46 | Metaphyseal cupping (HP:0003021) | 2.80273290 |
| 47 | Abnormality of oral frenula (HP:0000190) | 2.78350995 |
| 48 | Recurrent viral infections (HP:0004429) | 2.76981985 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.76379119 |
| 50 | B lymphocytopenia (HP:0010976) | 2.76379119 |
| 51 | Myelodysplasia (HP:0002863) | 2.73993529 |
| 52 | Obstructive sleep apnea (HP:0002870) | 2.70517851 |
| 53 | Oral leukoplakia (HP:0002745) | 2.69341480 |
| 54 | Muscle fiber atrophy (HP:0100295) | 2.64545947 |
| 55 | Deep palmar crease (HP:0006191) | 2.63381837 |
| 56 | Pointed chin (HP:0000307) | 2.61630416 |
| 57 | Combined immunodeficiency (HP:0005387) | 2.61429764 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.61328806 |
| 59 | Lymphoma (HP:0002665) | 2.60968232 |
| 60 | Amaurosis fugax (HP:0100576) | 2.59636995 |
| 61 | Meckel diverticulum (HP:0002245) | 2.59356279 |
| 62 | Lymphopenia (HP:0001888) | 2.57674709 |
| 63 | Abnormality of the preputium (HP:0100587) | 2.57657712 |
| 64 | Abnormality of the ileum (HP:0001549) | 2.57345066 |
| 65 | Bone marrow hypocellularity (HP:0005528) | 2.53675531 |
| 66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.52613161 |
| 67 | Increased connective tissue (HP:0009025) | 2.52354918 |
| 68 | Colitis (HP:0002583) | 2.51837552 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.49376796 |
| 70 | Chronic otitis media (HP:0000389) | 2.47626252 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.46239928 |
| 72 | Distal upper limb amyotrophy (HP:0007149) | 2.45199260 |
| 73 | Upper limb amyotrophy (HP:0009129) | 2.45199260 |
| 74 | Abnormality of the gallbladder (HP:0005264) | 2.44880946 |
| 75 | Myopathic facies (HP:0002058) | 2.41114031 |
| 76 | Patellar dislocation (HP:0002999) | 2.40493825 |
| 77 | Broad face (HP:0000283) | 2.39951815 |
| 78 | Nonimmune hydrops fetalis (HP:0001790) | 2.38893270 |
| 79 | Hypoplasia of the thymus (HP:0000778) | 2.37719743 |
| 80 | Pancytopenia (HP:0001876) | 2.37101888 |
| 81 | Abnormal hair whorl (HP:0010721) | 2.35968223 |
| 82 | Recurrent fungal infections (HP:0002841) | 2.34706712 |
| 83 | Insomnia (HP:0100785) | 2.34562192 |
| 84 | Abnormality of chromosome stability (HP:0003220) | 2.34545348 |
| 85 | Dysmetric saccades (HP:0000641) | 2.34291102 |
| 86 | Eczematoid dermatitis (HP:0000976) | 2.32647633 |
| 87 | Hypoproteinemia (HP:0003075) | 2.32637488 |
| 88 | Thyroiditis (HP:0100646) | 2.30963289 |
| 89 | Petechiae (HP:0000967) | 2.30073918 |
| 90 | Ileus (HP:0002595) | 2.29464368 |
| 91 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.28864445 |
| 92 | Long palpebral fissure (HP:0000637) | 2.28525450 |
| 93 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.27835071 |
| 94 | Chronic diarrhea (HP:0002028) | 2.25238233 |
| 95 | Cortical dysplasia (HP:0002539) | 2.24194011 |
| 96 | Granulocytopenia (HP:0001913) | 2.21633808 |
| 97 | Gonadotropin excess (HP:0000837) | 2.21066549 |
| 98 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19692159 |
| 99 | Abnormality of the anterior horn cell (HP:0006802) | 2.17087486 |
| 100 | Degeneration of anterior horn cells (HP:0002398) | 2.17087486 |
| 101 | Abnormality of the fingertips (HP:0001211) | 2.15809918 |
| 102 | Patellar aplasia (HP:0006443) | 2.15621980 |
| 103 | Abnormal number of erythroid precursors (HP:0012131) | 2.14937095 |
| 104 | Distal lower limb amyotrophy (HP:0008944) | 2.14198780 |
| 105 | Stridor (HP:0010307) | 2.13941480 |
| 106 | Neutropenia (HP:0001875) | 2.13908663 |
| 107 | Hemorrhage of the eye (HP:0011885) | 2.13689744 |
| 108 | Pulmonary fibrosis (HP:0002206) | 2.12166342 |
| 109 | Hand muscle atrophy (HP:0009130) | 2.12121300 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.10665727 |
| 111 | Eosinophilia (HP:0001880) | 2.09829610 |
| 112 | Severe visual impairment (HP:0001141) | 2.09430918 |
| 113 | Gastrointestinal dysmotility (HP:0002579) | 2.08108778 |
| 114 | Deep venous thrombosis (HP:0002625) | 2.07775788 |
| 115 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.07375845 |
| 116 | Cellular immunodeficiency (HP:0005374) | 2.07275792 |
| 117 | Duodenal stenosis (HP:0100867) | 2.05673349 |
| 118 | Small intestinal stenosis (HP:0012848) | 2.05673349 |
| 119 | 11 pairs of ribs (HP:0000878) | 2.05122848 |
| 120 | Abnormality of homocysteine metabolism (HP:0010919) | 2.04543501 |
| 121 | Homocystinuria (HP:0002156) | 2.04543501 |
| 122 | Premature graying of hair (HP:0002216) | 2.03562287 |
| 123 | Microretrognathia (HP:0000308) | 2.03470216 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 2.03158342 |
| 125 | Recurrent abscess formation (HP:0002722) | 2.02320424 |
| 126 | Microvesicular hepatic steatosis (HP:0001414) | 2.02134210 |
| 127 | Premature skin wrinkling (HP:0100678) | 2.01656174 |
| 128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00184333 |
| 129 | Agnosia (HP:0010524) | 2.00092485 |
| 130 | Clubbing of toes (HP:0100760) | 2.00082375 |
| 131 | Obsessive-compulsive behavior (HP:0000722) | 1.99766830 |
| 132 | Meningitis (HP:0001287) | 1.99485391 |
| 133 | Poikiloderma (HP:0001029) | 1.99430092 |
| 134 | Abnormally folded helix (HP:0008544) | 1.98207452 |
| 135 | Biconcave vertebral bodies (HP:0004586) | 1.98070988 |
| 136 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.98014355 |
| 137 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97855732 |
| 138 | Cerebral hypomyelination (HP:0006808) | 1.97492828 |
| 139 | Leukopenia (HP:0001882) | 1.96679043 |
| 140 | Heterotopia (HP:0002282) | 1.95714859 |
| 141 | Flat cornea (HP:0007720) | 1.93930029 |
| 142 | Attention deficit hyperactivity disorder (HP:0007018) | 1.93734230 |
| 143 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93711191 |
| 144 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93456953 |
| 145 | Increased IgE level (HP:0003212) | 1.92748730 |
| 146 | Pallor (HP:0000980) | 1.92402157 |
| 147 | IgA deficiency (HP:0002720) | 1.91767386 |
| 148 | Gastrointestinal inflammation (HP:0004386) | 1.91140716 |
| 149 | Cellulitis (HP:0100658) | 1.91113543 |
| 150 | Pendular nystagmus (HP:0012043) | 1.90410078 |
| 151 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.89184205 |
| 152 | Absent thumb (HP:0009777) | 1.88779944 |
| 153 | Overlapping toe (HP:0001845) | 1.88273208 |
| 154 | Optic nerve coloboma (HP:0000588) | 1.88132064 |
| 155 | Optic neuritis (HP:0100653) | 1.87739213 |
| 156 | Retrobulbar optic neuritis (HP:0100654) | 1.87739213 |
| 157 | Easy fatigability (HP:0003388) | 1.87045907 |
| 158 | Long eyelashes (HP:0000527) | 1.86968649 |
| 159 | Abnormality of the thoracic spine (HP:0100711) | 1.86441542 |
| 160 | Recurrent sinusitis (HP:0011108) | 1.85769833 |
| 161 | Vasculitis (HP:0002633) | 1.85031899 |
| 162 | Sparse lateral eyebrow (HP:0005338) | 1.82546758 |
| 163 | Venous abnormality (HP:0002624) | 1.82401730 |
| 164 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82167156 |
| 165 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82167156 |
| 166 | Abnormality of cochlea (HP:0000375) | 1.81668952 |
| 167 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.80616351 |
| 168 | Venous insufficiency (HP:0005293) | 1.80364284 |
| 169 | Leukocytosis (HP:0001974) | 1.78624534 |
| 170 | Broad palm (HP:0001169) | 1.76642201 |
| 171 | Thin bony cortex (HP:0002753) | 1.76133358 |
| 172 | Abnormality of the aortic arch (HP:0012303) | 1.75825388 |
| 173 | J-shaped sella turcica (HP:0002680) | 1.75285081 |
| 174 | Abnormality of the carotid arteries (HP:0005344) | 1.75142058 |
| 175 | Thin ribs (HP:0000883) | 1.74602010 |
| 176 | Cleft eyelid (HP:0000625) | 1.74492364 |
| 177 | Achilles tendon contracture (HP:0001771) | 1.74338713 |
| 178 | Sloping forehead (HP:0000340) | 1.73945874 |
| 179 | Decreased motor nerve conduction velocity (HP:0003431) | 1.73283719 |
| 180 | Macroorchidism (HP:0000053) | 1.71455733 |
| 181 | Hammertoe (HP:0001765) | 1.70731191 |
| 182 | Poikilocytosis (HP:0004447) | 1.69578937 |
| 183 | Cheekbone underdevelopment (HP:0010669) | 1.68629703 |
| 184 | Increased nuchal translucency (HP:0010880) | 1.67506614 |
| 185 | Sandal gap (HP:0001852) | 1.66932943 |
| 186 | Cerebral aneurysm (HP:0004944) | 1.66609305 |
| 187 | Abnormal hemoglobin (HP:0011902) | 1.66504919 |
| 188 | Ragged-red muscle fibers (HP:0003200) | 1.65572447 |
| 189 | Exercise-induced myalgia (HP:0003738) | 1.65085674 |
| 190 | Self-mutilation (HP:0000742) | 1.63784424 |
| 191 | Hyperbilirubinemia (HP:0002904) | 1.63513442 |
| 192 | Abnormality of the thymus (HP:0000777) | 1.63441126 |
| 193 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.62601058 |
| 194 | Fatigue (HP:0012378) | 1.61909827 |
| 195 | Progressive external ophthalmoplegia (HP:0000590) | 1.61700529 |
| 196 | Abnormality of the Achilles tendon (HP:0005109) | 1.60935377 |
| 197 | Flat acetabular roof (HP:0003180) | 1.60711087 |
| 198 | Breech presentation (HP:0001623) | 1.58889920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.50743832 |
| 2 | BUB1 | 3.88633657 |
| 3 | ICK | 3.60258170 |
| 4 | RIPK4 | 3.55938030 |
| 5 | CDK12 | 3.02026511 |
| 6 | MAP4K1 | 3.00165543 |
| 7 | KSR2 | 2.78837084 |
| 8 | STK16 | 2.69774715 |
| 9 | TXK | 2.60044492 |
| 10 | TESK2 | 2.57328008 |
| 11 | SMG1 | 2.53563102 |
| 12 | ERN1 | 2.50817991 |
| 13 | EIF2AK1 | 2.46817341 |
| 14 | SIK1 | 2.28826768 |
| 15 | WEE1 | 2.28710403 |
| 16 | ACVR1B | 2.26440810 |
| 17 | FGFR4 | 2.22924287 |
| 18 | TLK1 | 2.19050195 |
| 19 | SIK2 | 2.17207719 |
| 20 | TGFBR1 | 2.04644884 |
| 21 | SRPK1 | 2.04427914 |
| 22 | BRD4 | 2.01389910 |
| 23 | KIT | 2.01141447 |
| 24 | EPHB1 | 1.94493069 |
| 25 | ZAP70 | 1.94261647 |
| 26 | BTK | 1.90761402 |
| 27 | BRSK2 | 1.87715806 |
| 28 | TSSK6 | 1.82889071 |
| 29 | FLT3 | 1.80081636 |
| 30 | IRAK4 | 1.75767218 |
| 31 | MAP3K12 | 1.72381678 |
| 32 | CCNB1 | 1.69216815 |
| 33 | KDR | 1.68348228 |
| 34 | PASK | 1.66354797 |
| 35 | JAK3 | 1.58201497 |
| 36 | BLK | 1.54550477 |
| 37 | TEC | 1.49374887 |
| 38 | CDC7 | 1.49232843 |
| 39 | MAP3K2 | 1.46766365 |
| 40 | NTRK3 | 1.46239911 |
| 41 | IRAK3 | 1.45005816 |
| 42 | MAP2K3 | 1.44092838 |
| 43 | SIK3 | 1.43394972 |
| 44 | TBK1 | 1.42777224 |
| 45 | MARK2 | 1.42097114 |
| 46 | AKT3 | 1.38496331 |
| 47 | IKBKE | 1.38308193 |
| 48 | PRPF4B | 1.37517849 |
| 49 | BRSK1 | 1.35933047 |
| 50 | CSF1R | 1.35381720 |
| 51 | NEK2 | 1.35264005 |
| 52 | ATR | 1.27842151 |
| 53 | CDK8 | 1.25537699 |
| 54 | TESK1 | 1.24607456 |
| 55 | RAF1 | 1.24303067 |
| 56 | MAP3K7 | 1.19692970 |
| 57 | EIF2AK3 | 1.19432121 |
| 58 | TYRO3 | 1.17781357 |
| 59 | MAP3K6 | 1.17319205 |
| 60 | MAP3K8 | 1.15787832 |
| 61 | NME2 | 1.15587901 |
| 62 | TYK2 | 1.14999841 |
| 63 | PTK6 | 1.14444354 |
| 64 | MTOR | 1.14432938 |
| 65 | BMPR1B | 1.13279474 |
| 66 | CDK7 | 1.12491288 |
| 67 | MKNK1 | 1.11266192 |
| 68 | MYLK | 1.09990418 |
| 69 | SYK | 1.08092401 |
| 70 | RPS6KA4 | 1.07597784 |
| 71 | MAP3K14 | 1.06931870 |
| 72 | DAPK1 | 1.05664914 |
| 73 | ZAK | 1.05194087 |
| 74 | KSR1 | 1.03777148 |
| 75 | RIPK1 | 1.03397056 |
| 76 | YES1 | 1.03161852 |
| 77 | RET | 1.00208478 |
| 78 | EPHA3 | 0.98568448 |
| 79 | LCK | 0.98425124 |
| 80 | CAMK1D | 0.98205229 |
| 81 | PAK4 | 0.97993661 |
| 82 | ITK | 0.97705684 |
| 83 | VRK1 | 0.97676327 |
| 84 | LYN | 0.95546396 |
| 85 | STK10 | 0.95354960 |
| 86 | MAP3K1 | 0.94718837 |
| 87 | MAP3K13 | 0.90884033 |
| 88 | CDC42BPA | 0.90843723 |
| 89 | PLK4 | 0.90624994 |
| 90 | PIM2 | 0.89992632 |
| 91 | NME1 | 0.89254181 |
| 92 | DYRK3 | 0.88638221 |
| 93 | PRKD2 | 0.85494234 |
| 94 | IKBKB | 0.82816291 |
| 95 | PLK1 | 0.82416426 |
| 96 | TAOK1 | 0.81045930 |
| 97 | AURKB | 0.80186267 |
| 98 | BMX | 0.79263430 |
| 99 | JAK2 | 0.77694609 |
| 100 | BCKDK | 0.74673020 |
| 101 | CASK | 0.74591287 |
| 102 | MAPK12 | 0.73461053 |
| 103 | PIM1 | 0.72857943 |
| 104 | WNK1 | 0.72577914 |
| 105 | EIF2AK2 | 0.72463795 |
| 106 | CLK1 | 0.71477481 |
| 107 | FGFR3 | 0.70864063 |
| 108 | TAOK2 | 0.70846656 |
| 109 | STK4 | 0.68877368 |
| 110 | MKNK2 | 0.64278518 |
| 111 | RPS6KA2 | 0.64126601 |
| 112 | PDPK1 | 0.61841193 |
| 113 | FES | 0.61628005 |
| 114 | CDK19 | 0.59721472 |
| 115 | MAP3K10 | 0.58945601 |
| 116 | CHUK | 0.58738366 |
| 117 | NLK | 0.58646568 |
| 118 | BRAF | 0.57945375 |
| 119 | TTN | 0.57918122 |
| 120 | TNK2 | 0.56216058 |
| 121 | MAP2K2 | 0.55765357 |
| 122 | GRK6 | 0.55125312 |
| 123 | CHEK2 | 0.53500666 |
| 124 | CDK2 | 0.52945782 |
| 125 | ALK | 0.51690429 |
| 126 | CDK4 | 0.51410598 |
| 127 | HCK | 0.50170412 |
| 128 | CHEK1 | 0.50075942 |
| 129 | RPS6KB2 | 0.49572067 |
| 130 | HIPK2 | 0.48965819 |
| 131 | MAPK11 | 0.47859722 |
| 132 | JAK1 | 0.47676488 |
| 133 | EEF2K | 0.46516267 |
| 134 | LRRK2 | 0.46256537 |
| 135 | CDK1 | 0.44902638 |
| 136 | MARK3 | 0.44844170 |
| 137 | RPS6KL1 | 0.44281814 |
| 138 | RPS6KC1 | 0.44281814 |
| 139 | PDGFRA | 0.43327130 |
| 140 | MAPK10 | 0.43016265 |
| 141 | PKN2 | 0.42479259 |
| 142 | PRKAA1 | 0.42098197 |
| 143 | CAMK1G | 0.41113960 |
| 144 | CSNK2A1 | 0.41058521 |
| 145 | PRKD3 | 0.40043997 |
| 146 | PDK1 | 0.39772037 |
| 147 | TGFBR2 | 0.39480642 |
| 148 | MAPK8 | 0.39146919 |
| 149 | PLK3 | 0.38602679 |
| 150 | MAPK3 | 0.38098437 |
| 151 | PAK1 | 0.38043760 |
| 152 | STK38 | 0.37698377 |
| 153 | TTK | 0.37687563 |
| 154 | RPS6KA6 | 0.37123935 |
| 155 | CAMKK1 | 0.37006162 |
| 156 | CSK | 0.36538929 |
| 157 | DAPK3 | 0.33580801 |
| 158 | MAP2K6 | 0.33035474 |
| 159 | CSNK2A2 | 0.32304181 |
| 160 | MAP3K11 | 0.31934900 |
| 161 | ERBB3 | 0.31775579 |
| 162 | GSK3B | 0.31424659 |
| 163 | TIE1 | 0.30985699 |
| 164 | AKT1 | 0.30747705 |
| 165 | TNIK | 0.30630436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.68241753 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.97338062 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.95827466 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.52022041 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 3.40131040 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.86320693 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.80334057 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.77747436 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.75998807 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.71747259 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.34298764 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.30993355 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.26584887 |
| 14 | VEGF signaling pathway_Homo sapiens_hsa04370 | 2.21795804 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.19843971 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.08813546 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.08338122 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.06603067 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.98156359 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.93279469 |
| 21 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.80781998 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.80779271 |
| 23 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.79414793 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64875509 |
| 25 | Endometrial cancer_Homo sapiens_hsa05213 | 1.62085179 |
| 26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.60631461 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.55013589 |
| 28 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.54782022 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.51560348 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.47290977 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42732321 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.40936156 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40744274 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.40632992 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39746708 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.39307677 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.35978190 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.35965442 |
| 39 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.33912283 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.32008037 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28897625 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27790742 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.26824532 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25711553 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24451625 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23988097 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23859605 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 1.23660801 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.22282010 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.18298882 |
| 51 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.17180238 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12518767 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 1.12385281 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11459691 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11417307 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06841858 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06693978 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05296865 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98236488 |
| 60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.98185738 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97829215 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.96484079 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93905058 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92276496 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92126000 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92104946 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88790897 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88204440 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87732098 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87526858 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86302076 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83683401 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.83551121 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.83350107 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.82434579 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82336298 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81061537 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80674437 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80574554 |
| 80 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79721409 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.78660628 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.76747294 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76385688 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76185809 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75809697 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.72184259 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72053501 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70819473 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70137917 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69883729 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69357043 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69224965 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67017442 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.66992388 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66899707 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64562699 |
| 97 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.63106713 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62987493 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62134465 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61725053 |
| 101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60410227 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60035116 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59411551 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.58411620 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57466324 |
| 106 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57378766 |
| 107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56975804 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55609317 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51544121 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51403305 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51197072 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49972022 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48674402 |
| 114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48076779 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47342752 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45611079 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44096291 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43646865 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41868442 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41798370 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41028355 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.40870120 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.40591922 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.39014486 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38501026 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38185372 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37437275 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37229037 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37073490 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37071009 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37069674 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36989492 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36687539 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35476846 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34654968 |
| 136 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32795483 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32624936 |
| 138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31509892 |
| 139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30304654 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | 0.30014426 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29229360 |
| 142 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26985348 |
| 143 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25121990 |
| 144 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23988416 |
| 145 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.23249293 |
| 146 | Carbon metabolism_Homo sapiens_hsa01200 | 0.21574071 |
| 147 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.20830845 |
| 148 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20791170 |
| 149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20292757 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19607930 |
| 151 | Phagosome_Homo sapiens_hsa04145 | 0.18090845 |
| 152 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16962621 |

